Is it quinine TTP/HUS or quinine TMA? ADAMTS13 levels and implications for therapy.
- Published in:
- Journal of Clinical Apheresis, 2009, v. 24, n. 3, p. 115, doi. 10.1002/jca.20194
- By:
- Publication type:
- Article
Works matching IS 07332459 AND DT 2009 AND VI 24 AND IP 3
Results: 6
1
2
Red cell exchange transfusion for babesiosis in Rhode Island.
- Published in:
- Journal of Clinical Apheresis, 2009, v. 24, n. 3, p. 97, doi. 10.1002/jca.20197
- By:
- Publication type:
- Article
3
Preoperative therapeutic plasma exchange in patients with thyrotoxicosis.
- Published in:
- Journal of Clinical Apheresis, 2009, v. 24, n. 3, p. 111, doi. 10.1002/jca.20200
- By:
- Publication type:
- Article
4
TRALI risk reduction: Donor and component management strategies.
- Published in:
- Journal of Clinical Apheresis, 2009, v. 24, n. 3, p. 122, doi. 10.1002/jca.20198
- By:
- Publication type:
- Article
5
Value of ADAMTS13 activity and inhibitor in the postmortem diagnosis of thrombotic thrombocytopenic purpura.
- Published in:
- Journal of Clinical Apheresis, 2009, v. 24, n. 3, p. 106, doi. 10.1002/jca.20196
- By:
- Publication type:
- Article
6
Peripheral blood stem cell recovery following early termination of apheresis due to hypotension in a 4.8-kg infant.
- Published in:
- Journal of Clinical Apheresis, 2009, v. 24, n. 3, p. 120, doi. 10.1002/jca.20195
- By:
- Publication type:
- Article